Page last updated: 2024-08-24

geranylgeraniol and Precancerous Conditions

geranylgeraniol has been researched along with Precancerous Conditions in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Conti, A; de Moura EspĂ­ndola, R; Heidor, R; Mazzantini, RP; Moreno, FS; Ong, TP1

Other Studies

1 other study(ies) available for geranylgeraniol and Precancerous Conditions

ArticleYear
Geranylgeraniol and beta-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-kappaB activation.
    Carcinogenesis, 2005, Volume: 26, Issue:6

    Topics: Animals; Anticarcinogenic Agents; Apoptosis; Cell Proliferation; Cholesterol; Corn Oil; Diterpenes; DNA Damage; Enzyme Activation; Hepatocytes; Liver Neoplasms, Experimental; Male; NF-kappa B; Norisoprenoids; Precancerous Conditions; Rats; Rats, Wistar; Transcription Factor RelA

2005